Azenta, Inc. Appoints Interim CEO; Details Pay and Retention Awards

What Happened
Azenta, Inc. filed an 8-K on Sept. 17, 2026 disclosing terms for Interim President and CEO Dr. Martin D. Madaus, effective Aug. 22, 2026, and one-time retention restricted stock unit (RSU) awards for four named executives. The Board approved a letter agreement with Dr. Madaus on Sept. 14, 2026 setting his cash and equity compensation and reconstituted the Nominating and Governance Committee (Dr. Madaus ceased membership).

Key Details

• Interim CEO pay: annual base salary $600,000 (effective Aug. 22, 2026) and a cash performance recognition bonus equal to 100% of base salary ($600,000) in lieu of annual incentive; bonus vests in full on the one-year anniversary of the Start Date (or pro rata on earlier termination) and is payable as a lump sum on Jan. 1, 2028, subject to a signed, non-revoked release and forfeiture for Cause or voluntary resignation (other than at Board request).
• Interim CEO equity: $1,200,000 award value in restricted stock units granted as of Sept. 14, 2026; number of RSUs = $1,200,000 ÷ average closing price over the prior 20 trading days; vests 1/12 each month beginning Aug. 22, 2026, subject to continued service; subject to Azenta’s Plan, standard RSU agreement and Clawback Policy.
• Named executive retention awards (granted Sept. 14, 2026): Lawrence Lin (CFO) $1,000,000; Ephraim Starr (GC) $500,000; Olga Pirogova (CHRO) $500,000; Trey Martin (President, Multiomics) $500,000. Each award = RSUs (award value ÷ 20-day average price), time-based: 50% vests on each of the first and second anniversaries; certain terminations by the company (other than for Cause) or for Good Reason accelerate partial or full vesting.
• Employment terms: Dr. Madaus’s employment is at-will; he is eligible for standard benefit plans but will not participate in Azenta’s severance or change-in-control policies.

Why It Matters
These actions define compensation and retention incentives during a CEO transition. The mix of cash and equity (notably the $1.2M RSU grant for the interim CEO and multi-hundred-thousand-dollar RSU retention awards for senior officers) is designed to retain leadership and align their interests with stock performance over the vesting periods. For investors, the awards may affect near-term compensation expense and could lead to future issuance of shares if RSUs vest; they also clarify that the interim CEO is not covered by severance or change-in-control protections.